These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 27515028)

  • 1. Prognostic significance of preoperative serum Krebs von den Lungen-6 level in non-small cell lung cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Gen Thorac Cardiovasc Surg; 2016 Nov; 64(11):657-661. PubMed ID: 27515028
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Krebs von den Lungen-6 (KL-6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer.
    Tanaka S; Hattori N; Ishikawa N; Shoda H; Takano A; Nishino R; Okada M; Arihiro K; Inai K; Hamada H; Yokoyama A; Kohno N
    Int J Cancer; 2012 Jan; 130(2):377-87. PubMed ID: 21351094
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Krebs von den Lungen-6 associated with chest high-resolution CT score in evaluation severity of patients with interstitial lung disease.
    Qin H; Xu XP; Zou J; Zhao XJ; Wu HW; Zha QF; Chen S; Kang Y; Jiang HD
    Pulmonology; 2019; 25(3):143-148. PubMed ID: 30007895
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Elevated serum Krebs von den Lungen-6 in systemic sclerosis: a marker of lung fibrosis and severity of the disease.
    Benyamine A; Heim X; Resseguier N; Bertin D; Gomez C; Ebbo M; Harlé JR; Kaplanski G; Rossi P; Bardin N; Granel B
    Rheumatol Int; 2018 May; 38(5):813-819. PubMed ID: 29455320
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The value of serum Krebs von den lungen-6 as a diagnostic marker in connective tissue disease associated with interstitial lung disease.
    Ma H; Lu J; Song Y; Wang H; Yin S
    BMC Pulm Med; 2020 Jan; 20(1):6. PubMed ID: 31915006
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Usefulness of monitoring the circulating Krebs von den Lungen-6 levels to predict the clinical outcome of patients with advanced nonsmall cell lung cancer treated with epidermal growth factor receptor tyrosine kinase inhibitors.
    Ishikawa N; Hattori N; Yokoyama A; Tanaka S; Nishino R; Yoshioka K; Ohshimo S; Fujitaka K; Ohnishi H; Hamada H; Arihiro K; Kohno N
    Int J Cancer; 2008 Jun; 122(11):2612-20. PubMed ID: 18324627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictive Impact for Postoperative Recurrence of Preoperative Serum Krebs von den Lungen-6 Concentration in Pathologic Stage IA Non-Small Cell Lung Cancer.
    Shoji F; Yamazaki K; Kouso H; Mori R; Takeo S
    Ann Thorac Surg; 2016 May; 101(5):1903-8. PubMed ID: 26912302
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of serum KL-6 levels with interstitial lung disease in patients with connective tissue disease: a cross-sectional study.
    Oguz EO; Kucuksahin O; Turgay M; Yildizgoren MT; Ates A; Demir N; Kumbasar OO; Kinikli G; Duzgun N
    Clin Rheumatol; 2016 Mar; 35(3):663-6. PubMed ID: 26758437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum KL-6 levels in lung cancer patients with or without interstitial lung disease.
    Miyazaki K; Kurishima K; Kagohashi K; Kawaguchi M; Ishikawa H; Satoh H; Hizawa N
    J Clin Lab Anal; 2010; 24(5):295-9. PubMed ID: 20872562
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnostic Value of Krebs von den Lungen (KL-6) for Interstitial Lung Disease: A European Prospective Cohort.
    Millan-Billi P; Castellví I; Martinez-Martinez L; Mariscal A; Barril S; D'Alessandro M; Franquet T; Castillo D
    Arch Bronconeumol; 2024 Jun; 60(6):350-355. PubMed ID: 38644152
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serum Krebs von den Lungen-6 concentrations reflect severity of anti-melanoma differentiation-associated protein 5 antibody positive dermatomyositis associated interstitial lung disease.
    Zhu Y; Wang L; Sun Y; Wang J; Lv C; You H; Xu L; Wang F; Zhang M; Tan W; Ke Y
    Clin Exp Rheumatol; 2022 Feb; 40(2):292-297. PubMed ID: 34874831
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Usefulness of serum Krebs von den Lungen-6 for the management of myositis-associated interstitial lung disease.
    Takanashi S; Nishina N; Nakazawa M; Kaneko Y; Takeuchi T
    Rheumatology (Oxford); 2019 Jun; 58(6):1034-1039. PubMed ID: 30624752
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the clinical performance of the HISCL-5000 analyzer in the detection of Krebs von den Lungen-6 antigen and its diagnostic value in interstitial lung disease.
    Wang J; Huang Z; Xue M; Huang H; Zheng X; Zhong N; Sun B
    J Clin Lab Anal; 2020 Feb; 34(2):e23070. PubMed ID: 31691368
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic role of KL-6 in SSc-ILD patients with pleuroparenchymal fibroelastosis.
    d'Alessandro M; Bellisai F; Bergantini L; Cameli P; D'Alessandro R; Mazzei MA; Gentili F; Conticini E; Selvi E; Frediani B; Matucci-Cerinic M; Bargagli E
    Eur J Clin Invest; 2021 Aug; 51(8):e13543. PubMed ID: 33759179
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Elevated Serum Krebs von den Lungen-6 in Early Disease Predicts Subsequent Deterioration of Pulmonary Function in Patients with Systemic Sclerosis and Interstitial Lung Disease.
    Kuwana M; Shirai Y; Takeuchi T
    J Rheumatol; 2016 Oct; 43(10):1825-1831. PubMed ID: 27481907
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Krebs von den Lungen-6 as biomarker of the new progressive fibrotic phenotype of interstitial lung disease.
    d'Alessandro M; Conticini E; Bergantini L; Mazzei MA; Bellisai F; Selvi E; Cameli P; Frediani B; Bargagli E
    Tissue Cell; 2024 Oct; 90():102516. PubMed ID: 39137538
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Elevated serum level of sialylated glycoprotein KL-6 predicts a poor prognosis in patients with non-small cell lung cancer treated with gefitinib.
    Fujiwara Y; Kiura K; Toyooka S; Hotta K; Tabata M; Takigawa N; Soh J; Tanimoto Y; Kanehiro A; Kato K; Date H; Tanimoto M
    Lung Cancer; 2008 Jan; 59(1):81-7. PubMed ID: 17765355
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prognostic Significance of a Tumor Marker Index Based on Preoperative Serum Carcinoembryonic Antigen and Krebs von den Lungen-6 Levels in Non-Small Cell Lung Cancer.
    Tomita M; Ayabe T; Chosa E; Nose N; Nakamura K
    Asian Pac J Cancer Prev; 2017 Jan; 18(1):287-291. PubMed ID: 28240848
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serum YKL-40 and Serum Krebs von den Lungen-6 as Potential Predictive Biomarkers for Rheumatoid Arthritis-Associated Interstitial Lung Disease.
    Liang B; Zhang Y; Ke D; Yan R; Jiang MN; Li L; Zhang LX; Zhao XG; Yuan GP; Xu B; Liu XM
    Immunol Invest; 2024 Aug; 53(6):989-1000. PubMed ID: 38900045
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum KL-6 levels reflect the severity of interstitial lung disease associated with connective tissue disease.
    Lee JS; Lee EY; Ha YJ; Kang EH; Lee YJ; Song YW
    Arthritis Res Ther; 2019 Feb; 21(1):58. PubMed ID: 30764869
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.